Karen Sleeman, N.P

NPI: 1275532228
Total Payments
$5,848
2024 Payments
$453.32
Companies
32
Transactions
228
Medicare Patients
1,005
Medicare Billing
$79,135

Payment Breakdown by Category

Food & Beverage$3,743 (64.0%)
Other$1,531 (26.2%)
Education$574.08 (9.8%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $3,743 204 64.0%
Long term medical supply or device loan $1,531 17 26.2%
Education $574.08 7 9.8%

Top Paying Companies

Company Total Records Latest Year
Novartis Pharmaceuticals Corporation $1,652 23 $0 (2023)
PFIZER INC. $531.59 27 $0 (2024)
Astellas Pharma US Inc $389.91 9 $0 (2022)
GlaxoSmithKline, LLC. $348.07 11 $0 (2023)
Janssen Biotech, Inc. $346.52 14 $0 (2024)
AstraZeneca Pharmaceuticals LP $292.46 16 $0 (2024)
Myriad Genetic Laboratories, Inc. $292.32 8 $0 (2024)
Merck Sharp & Dohme LLC $258.47 15 $0 (2024)
Amgen Inc. $209.57 15 $0 (2022)
Takeda Pharmaceuticals U.S.A., Inc. $199.48 10 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $453.32 14 Myriad Genetic Laboratories, Inc. ($192.04)
2023 $1,010 47 Novartis Pharmaceuticals Corporation ($262.78)
2022 $1,405 56 Novartis Pharmaceuticals Corporation ($358.32)
2021 $2,979 111 Novartis Pharmaceuticals Corporation ($1,031)

All Payment Transactions

228 individual payment records from CMS Open Payments — Page 1 of 10

Date Company Product Nature Form Amount Type
11/13/2024 AstraZeneca Pharmaceuticals LP CALQUENCE (Drug) Food and Beverage In-kind items and services $14.08 General
Category: Oncology
10/31/2024 Merck Sharp & Dohme LLC KEYTRUDA (Biological), LYNPARZA Food and Beverage In-kind items and services $15.00 General
Category: ONCOLOGY
10/22/2024 Myriad Genetic Laboratories, Inc. PRECISETUMOR (Device) Food and Beverage In-kind items and services $12.12 General
Category: ONCOLOGY
08/15/2024 Myriad Genetic Laboratories, Inc. PRECISETUMOR (Device) Food and Beverage In-kind items and services $43.59 General
Category: ONCOLOGY
07/29/2024 Merck Sharp & Dohme LLC Food and Beverage In-kind items and services $14.90 General
06/05/2024 AstraZeneca Pharmaceuticals LP CALQUENCE (Drug) Food and Beverage In-kind items and services $23.77 General
Category: Oncology
05/07/2024 PFIZER INC. Education In-kind items and services $99.95 General
03/19/2024 Merck Sharp & Dohme LLC KEYTRUDA (Biological) Food and Beverage In-kind items and services $14.19 General
Category: ONCOLOGY
03/12/2024 Janssen Biotech, Inc. RYBREVANT (Drug) Food and Beverage In-kind items and services $23.88 General
Category: Oncology
03/06/2024 Myriad Genetic Laboratories, Inc. PRECISETUMOR (Device) Food and Beverage In-kind items and services $126.40 General
Category: ONCOLOGY
01/31/2024 Myriad Genetic Laboratories, Inc. PRECISETUMOR (Device) Food and Beverage In-kind items and services $9.93 General
Category: ONCOLOGY
01/18/2024 GENZYME CORPORATION SARCLISA (Biological) Food and Beverage In-kind items and services $18.65 General
Category: Oncology
01/09/2024 Merck Sharp & Dohme LLC KEYTRUDA (Biological), WELIREG Food and Beverage In-kind items and services $19.68 General
Category: ONCOLOGY
01/04/2024 PharmaEssentia USA Corporation BESREMI (Drug) Food and Beverage In-kind items and services $17.18 General
Category: Oncology
12/20/2023 Janssen Biotech, Inc. ERLEADA (Drug) Food and Beverage In-kind items and services $21.64 General
Category: Oncology
12/13/2023 Myriad Genetic Laboratories, Inc. PRECISETUMOR (Device) Food and Beverage In-kind items and services $49.53 General
Category: ONCOLOGY
12/13/2023 Myriad Genetic Laboratories, Inc. PRECISETUMOR (Device) Food and Beverage In-kind items and services $14.15 General
Category: ONCOLOGY
12/12/2023 GlaxoSmithKline, LLC. OJJAARA (Drug) Food and Beverage In-kind items and services $19.83 General
Category: ONCOLOGY
12/07/2023 BeiGene USA, Inc. BRUKINSA (Drug) Food and Beverage In-kind items and services $16.66 General
Category: Oncology
11/27/2023 Celgene Corporation Pomalyst (Drug) Food and Beverage Cash or cash equivalent $18.47 General
Category: Hematology
11/21/2023 Novartis Pharmaceuticals Corporation PROMACTA (Drug) Food and Beverage In-kind items and services $19.88 General
Category: Oncology
11/20/2023 Janssen Biotech, Inc. RYBREVANT (Drug) Food and Beverage In-kind items and services $16.00 General
Category: Oncology
11/15/2023 AVEO Pharmaceuticals, Inc. FOTIVDA (Drug) Food and Beverage In-kind items and services $15.50 General
Category: Oncology
11/01/2023 Stemline Therapeutics Inc. Orserdu (Drug) Food and Beverage In-kind items and services $13.60 General
Category: Oncology
10/30/2023 Ipsen Biopharmaceuticals, Inc Tazverik (Drug) Food and Beverage In-kind items and services $20.50 General
Category: Oncology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 3 199 265 $62,477 $12,967
2022 3 271 403 $89,861 $19,797
2021 3 280 500 $96,174 $26,440
2020 3 255 560 $52,741 $19,931
Total Patients
1,005
Total Services
1,728
Medicare Billing
$79,135
Procedure Codes
14

All Medicare Procedures & Services

14 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2023 108 138 $24,840 $5,509 22.2%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2023 25 53 $18,767 $4,651 24.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 66 74 $18,870 $2,806 14.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2022 150 233 $41,875 $8,134 19.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 66 78 $19,890 $4,851 24.4%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2022 21 56 $19,936 $4,816 24.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 22 24 $6,000 $1,522 25.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 12 12 $2,160 $473.83 21.9%
99213 Established patient outpatient visit, total time 20-29 minutes Facility 2021 177 303 $48,978 $12,767 26.1%
99215 Established patient outpatient visit, total time 40-54 minutes Facility 2021 43 115 $30,710 $9,871 32.1%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 60 82 $16,486 $3,802 23.1%
99213 Established patient office or other outpatient visit, typically 15 minutes Facility 2020 187 380 $23,001 $11,422 49.7%
99214 Established patient office or other outpatient, visit typically 25 minutes Facility 2020 50 161 $28,336 $8,203 28.9%
99212 Established patient office or other outpatient visit, typically 10 minutes Facility 2020 18 19 $1,404 $306.46 21.8%

About Karen Sleeman, N.P

Karen Sleeman, N.P is a Adult Health healthcare provider based in Jamestown, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1275532228.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Karen Sleeman, N.P has received a total of $5,848 in payments from pharmaceutical and medical device companies, with $453.32 received in 2024. These payments were reported across 228 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($3,743).

As a Medicare-enrolled provider, Sleeman has provided services to 1,005 Medicare beneficiaries, totaling 1,728 services with total Medicare billing of $79,135. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.

Practice Information

  • Specialty Adult Health
  • Location Jamestown, NY
  • Active Since 07/20/2005
  • Last Updated 05/05/2014
  • Taxonomy Code 363LA2200X
  • Entity Type Individual
  • NPI Number 1275532228

Products in Payments

  • KISQALI (Drug) $1,365
  • XTANDI (Drug) $333.74
  • PRECISETUMOR (Device) $292.32
  • ZEJULA (Drug) $265.66
  • KEYTRUDA (Biological) $243.57
  • IMBRUVICA (Drug) $198.58
  • Lenvima (Drug) $180.29
  • CALQUENCE (Drug) $160.47
  • OPDIVO (Biological) $107.81
  • SARCLISA (Biological) $101.86
  • BRAFTOVI (Drug) $89.72
  • INJECTAFER (Drug) $78.31
  • IBRANCE (Drug) $77.57
  • XARELTO (Drug) $71.45
  • LUMAKRAS (Drug) $70.10
  • PROMACTA (Drug) $65.25
  • IMFINZI (Biological) $64.19
  • NINLARO (Drug) $62.26
  • ERLEADA (Drug) $61.41
  • Tazverik (Drug) $61.17

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Adult Health Doctors in Jamestown